Ainos (NASDAQ:AIMD – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.09) EPS for the quarter, FiscalAI reports.
Ainos Stock Performance
Shares of Ainos stock opened at $1.23 on Monday. The stock has a market cap of $10.73 million, a price-to-earnings ratio of -0.49 and a beta of 2.66. The stock has a 50 day moving average price of $1.09 and a 200-day moving average price of $1.54. Ainos has a one year low of $0.43 and a one year high of $3.88.
Analyst Ratings Changes
Separately, Weiss Ratings raised Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, September 25th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.
Read Our Latest Analysis on AIMD
About Ainos
Ainos, Inc. is a health technology company developing products that combine artificial intelligence with sensing and diagnostic technologies. Its work includes the AI Nose platform, designed to detect and analyze volatile organic compounds (VOCs) for potential use in health care and other applications. The company also develops VELDONA, a low-dose interferon-alpha product, and point-of-care testing solutions. Ainos focuses on advancing these offerings for human and veterinary health uses, alongside applications for VOC monitoring.
Further Reading
- Five stocks we like better than Ainos
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
